The FDA is getting ready to finalize its four-and-a-half year-old draft guidance on quantitative efficacy and risk information in direct-to-consumer (DTC) advertising. According to a Federal Register notice (88 Fed. Reg. 19313), FDA is “preparing to finalize the guidance document to clarify considerations for quantitative efficacy or risk presentations across various media ty... Read More